Evidence map›Paper›PMID 10082538›Full record

ArticleMolecular and cellular biology1999

Human SWI-SNF component BRG1 represses transcription of the c-fos gene.

D J Murphy, S Hardy, D A Engel

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Bromodomain containing 9 (BRD9) regulates macrophage inflammatory responses by potentiating glucocorticoid receptor activity.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

D J MurphyDepartment of Microbiology and Cancer Center, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
S Hardy
D A Engel
University of Virginia · USGenesys (United States) · US

Funding

ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEXR01CA060675 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ENGEL, DANIEL A · 2001 to 2005
$1.1M
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTIONR29CA060675 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ENGEL, DANIEL A · 1995 to 1999
–
NCI NIH HHS CA60675NCI NIH HHS R01 CA060675NCI NIH HHS R29 CA060675
6 · The paper itself

Abstract

Yeast and mammalian SWI-SNF complexes regulate transcription through active modification of chromatin structure. Human SW-13 adenocarcinoma cells lack BRG1 protein, a component of SWI-SNF that has a DNA-dependent ATPase activity essential for SWI-SNF function. Expression of BRG1 in SW-13 cells potentiated transcriptional activation by the glucocorticoid receptor, which is known to require SWI-SNF function. BRG1 also specifically repressed transcription from a transfected c-fos promoter and correspondingly blocked transcriptional activation of the endogenous c-fos gene. Mutation of lysine residue 798 in the DNA-dependent ATPase domain of BRG1 significantly reduced its ability to repress c-fos transcription. Repression by BRG1 required the cyclic AMP response element of the c-fos promoter but not nearby binding sites for Sp1, YY1, or TFII-I. Using human C33A cervical carcinoma cells, which lack BRG1 and also express a nonfunctional Rb protein, transcriptional repression by BRG1 was weak unless wild-type Rb was also supplied. Interestingly, Rb-dependent repression by BRG1 was found to take place through a pathway that is independent of transcription factor E2F.

Indexed as

Carrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsDNA HelicasesGene Expression Regulation, NeoplasticGenes, fosActivating Transcription FactorsAdenocarcinomaAdenosine TriphosphatasesBase SequenceBlood ProteinsCyclic AMP Response Element-Binding ProteinE2F Transcription FactorsHumansMolecular Sequence DataNuclear ProteinsActivating Transcription FactorsAdenosine TriphosphatasesBlood ProteinsCarrier ProteinsCell Cycle ProteinsCyclic AMP Response Element-Binding ProteinDNA-Binding ProteinsDNA HelicasesE2F Transcription FactorsNuclear ProteinsProto-Oncogene Proteins c-fosRecombinant ProteinsRepressor ProteinsRetinoblastoma-Binding Protein 1Retinoblastoma ProteinSMARCA4 protein, humanTranscription Factor DP1Transcription Factors

Identifiers

PMID10082538
PMCPMC84065
OpenAlexW2171070802

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.